A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception

Dragoman, Monica V., Tepper, Naomi K., Fu, Rongwei, Curtis, Kathryn M., Chou, Roger, Gaffield, Mary E.·2018·International Journal of Gynecology & Obstetrics
DOI 10.1002/ijgo.12455

Cited by (252)

Items 101–200 of 252

  1. An endocrine perspective on menstrual suppression for adolescents: achieving good suppression while optimizing bone health
    Amit Lahoti, Christine Yu, Preneet Cheema Brar, Austin Dalgo, Evgenia Gourgari, Rebecca M. Harris, Manmohan K. Kamboj, Seth D. Marks, Radha Nandagopal, LAURA C. PAGE et al. · 2021 · Journal of Pediatric Endocrinology and Metabolism
  2. Os anticoncepcionais orais como fator de risco cardiovascular: uma revisão narrativa
    Thiago Mendes dos Santos, Manuela de Matos Costa de Menezes, Mariana Pereato Fernandes, Giovana Lopes Nadais, Maria Fernanda de Almeida Gomes, Serginara Cristina Flexa Pereira da Silva, Rebeca Fernandes de Azevedo Dantas, Maria Eduarda Barillari Cano, Bruno Augusto Lopes · 2021 · Revista Eletrônica Acervo Saúde
  3. The challenging role of antiandrogens in the management of polycystic ovary syndrome
    Kasiani Papadimitriou, Panagiotis G. Anagnostis, Dimitrios G. Goulis · 2021 · Elsevier eBooks
  4. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception
    Shaalini Ramanadhan, Katie Hansen, Jillian T. Henderson, Megan A. Cohen, Robin A. Paynter, Alison B. Edelman · 2023 · Cochrane Database of Systematic Reviews
  5. Discovery of small molecule binders of human FSHR(TMD) with novel structural scaffolds by integrating structural bioinformatics and machine learning algorithms
    Bhawana Sahu, Sanchi Shah, Kaushiki S. Prabhudesai, Alessandro Contini, Susan Idicula‐Thomas · 2019 · Journal of Molecular Graphics and Modelling
  6. Thromboembolic events associated with combined oral contraceptives: a real-world study based on the FDA adverse event reporting system (FAERS) database
    Yanhong Liu, Guixin Zhao, Rong Feng · 2024 · Expert Opinion on Drug Safety
  7. Principles of management of women with hirsutism – a dermatologist’s perspective
    Dominik Mikiel, Barbara Olszewska, Adriana Polańska, Zygmunt Adamski, Ryszard Wiesław Żaba, Aleksandra Dańczak‐Pazdrowska · 2020 · Dermatology Review
  8. Actividades preventivas en la mujer. Actualización PAPPS 2024
    Alberto López García‐Franco, Pablo Alonso‐Coello, Ana Pereira Iglesias, Cristina González Fernádez, Elisa Romero Pineda, Jacinta Landa Goñi · 2024 · Atención Primaria
  9. Contraceptive use among women with inflammatory bowel disease: An updated systematic review
    Lauren B. Zapata, Emily M Snyder, Naomi K. Tepper, Kathryn M. Curtis · 2025 · Contraception
  10. The New Low-Dose Transdermal Contraceptive System (Twirla ® ): Results from Preclinical and Phase III Trials
    Anita L. Nelson · 2021 · Therapeutic Delivery
  11. Characteristics and gender affirming healthcare needs of transgender and non-binary students starting hormone therapy in a student health service in Aotearoa New Zealand
    Rona Carroll, Bianca Sepulveda, Lane McLeod, Cathy Stephenson, Richard W. Carroll · 2023 · Journal of Primary Health Care
  12. (Dis)continuation of the oral contraceptive pill: A focus group approach in the Netherlands
    Rebecca S. Otte, V.T.M. Thissen, Bob C. Mulder · 2023 · Heliyon
  13. Diretriz Brasileira sobre a Saúde Cardiovascular no Climatério e na Menopausa – 2024
    Gláucia Maria Moraes de Oliveira, Maria Cristina Costa de Almeida, Carolina Artucio, Larissa Neto Espíndola, Maria Alayde Mendonça Rivera, Agnaldo Lopes da Silva Filho, Celi Marques-Santos, César Eduardo Fernandes, Carlos Japhet da Matta Albuquerque, Cláudia Maria Vilas Freire et al. · 2024 · Arquivos Brasileiros de Cardiologia
  14. Treatment of Cardiovascular Manifestations in Transgender Individuals
    Azin Karimian, Kasra Shokri, Abbas Mohammadi, William H. Frishman, Wilbert S. Aronow · 2025 · Cardiology in Review
  15. Contraception dans le contexte du syndrome des ovaires polykystiques
    Poli Mara Spritzer · 2022 · médecine/sciences
  16. Effects of Peroral Hormonal Contraception on Cardiovascular System: Analysis of Selected Cardiovascular Parameters in an Adolescent Cohort; a Pilot Project
    Ondřej Pírek, Ksenia Budinskaya, Zuzana Nováková · 2022 · Physiological Research
  17. Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database
    Luis H. Martín Arias, María Sáinz-Gil, Ester Navarro-García, Inés Salado Valdivieso, Rosario Sanz Fadrique · 2022 · Drugs - Real World Outcomes
  18. Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
    Yeri Lee, Ahhyung Choi, Yunha Noh, Ha‐Lim Jeon, Seung‐Ah Choe, Ju‐Young Shin · 2021 · BMJ Open
  19. The use of combined hormonal contraceptives amid the COVID-19 pandemic
    Chia Siang Kow, Zia Ul Mustafa, Syed Shahzad Hasan · 2020 · The European Journal of Contraception & Reproductive Health Care
  20. Aortic mural thrombosis with bilateral renal infarction in a woman taking dienogest for adenomyosis: A case report and literature review
    Kuang-Yen Lee, Chieh‐Lung Cheng, Ying‐Cheng Chiang · 2025 · Taiwanese Journal of Obstetrics and Gynecology
  21. Hormonal Contraception in Perimenopause: What to Consider to Guide the Choice
    Tiziana Fidecicchi, Marta Caretto, Giulia Chen, Davide Simi, Maria Magdalena Montt Guevara, Andrea Giannini, Stefano Vincenzo Luisi, Tommaso Simoncini · 2025 · Seminars in Reproductive Medicine
  22. Venous thromboembolism in users of progestin-only hormonal contraception in Sweden: a prospective, register-based, nested, matched case–control study
    Anna L. Eriksson, Erik Östgärd Thunström, Jari Martikainen, Georgios Lappas, Annika Rosengren, Jenny M. Kindblom · 2026 · The Lancet Obstetrics Gynaecology & Women s Health
  23. Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6
    Jan de Jong, Anna Mitselos, Wojciech J. Jurczak, Raúl Córdoba, Carlos Panizo, Tomasz Wróbel, Monika Długosz‐Danecka, James Juhui Jiao, Juthamas Sukbuntherng, Danièle Ouellet et al. · 2020 · Pharmacology Research & Perspectives
  24. Recommendations for risk minimization when using Janus kinase inhibitors for the treatment of chronic inflammatory skin diseases
    Johannes Wohlrab, Thomas Kegel, Regina Große, Adina Eichner · 2023 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  25. Brazilian Guideline on Menopausal Cardiovascular Health – 2024
    Gláucia Maria Moraes de Oliveira, Maria Cristina Costa de Almeida, Carolina Artucio, Larissa Neto Espíndola, Maria Alayde Mendonça Rivera, Agnaldo Lopes da Silva Filho, Celi Marques-Santos, César Eduardo Fernandes, Carlos Japhet da Matta Albuquerque, Cláudia Maria Vilas Freire et al. · 2024 · Revista Brasileira Ginecologia e Obstetrícia
  26. Actividades preventivas en la mujer. Actualización PAPPS 2020
    Alberto López García‐Franco, José Antonio Baeyens Fernández, Emilia Bailón Muñoz, M. José Iglesias Piñeiro, Amparo Ortega del Moral, Pablo Alonso‐Coello, Cristina Ruiz Cabello, Jacinta Landa Goñi, Lorenzo Arribas Mir · 2020 · Atención Primaria
  27. Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims Data
    Oliver H. F. Scholle, Antje C. Neubert, Oliver Riedel, Irmgard Toni, Ulrike Haug · 2021 · Frontiers in Pharmacology
  28. Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient
    Marcel Kemper, Georg Lenz, Rolf Michael Mesters · 2021 · Acta Haematologica
  29. Pharmacoepidemiological Analysis of Oral Contraceptive Use in Adolescents in a German Longitudinal Cohort Study
    Markus Herzig, Astrid Bertsche, Cornelia Hilbert, Wieland Kieß, Thilo Bertsche, Martina Patrizia Neininger · 2023 · Children
  30. Adrenocorticotropic hormone secretion in response to anticipatory stress and venepuncture: The role of menstrual phase and oral contraceptive use
    Marie Vadstrup Pedersen, Line Mathilde Brostrup Hansen, Benjamin Garforth, Paul J. Zak, Michael Winterdahl · 2023 · Behavioural Brain Research
  31. Combined oral contraceptives: update recommendations of the Latin American contraceptive association
    Santiago Palacios, Gabriela Ayala, G González, Can L. Badilla-Apuy, Marchena Jeannette, Katia Martínez, Desireé Mostajo, María S. Vernaza, Alejandro Paradas, Luis Hernández et al. · 2023 · Gynecological Endocrinology
  32. Contraceptive Challenges in Women With Common Medical Conditions
    Mary L. Marnach, Cassandra J. Gave, Petra M. Casey · 2020 · Mayo Clinic Proceedings
  33. Drospirenone: a Latin American perspective for oestrogen-free oral contraception
    Carolina Sales Vieira, Cuauhtémoc Celis, Guillermo Galán, Luis Hernández, Ivonne Díaz, Jorge López Berroa · 2020 · The European Journal of Contraception & Reproductive Health Care
  34. Hormonelle orale Kontrazeption – welches Präparat für welche Patientin?
    Thomas Römer · 2021 · Gynäkologische Endokrinologie
  35. Conhecimento de universitárias sobre os riscos e benefícios associados aos contraceptivos orais combinados
    Laís Ferraz de Assis Pinto, Fernanda Vieira Rodovalho Callegari, Maristela Carbol · 2020 · Revista de Medicina
  36. Selecting optimal progestational agents either alone or in combination in common pediatric endocrine settings: challenges of unmet needs
    Jenna A. Reich, Deepa Badrinath Murthy, Chanelle Coble, Bina Cherryl Shah · 2024 · Journal of Pediatric Endocrinology and Metabolism
  37. Efficacy and safety of safflower yellow combined with low molecular weight heparin in preventing deep vein thrombosis after orthopedic surgery: a systematic review and meta-analysis
    Qiuyu Li · 2024 · American Journal of Translational Research
  38. Protective effect of estradiol copreservation against kidney ischemia‐reperfusion injury
    Dawei Zhou, Junto Leung, Weichen Xu, Shaojun Ye, Caitao Dong, Wanbin Huang, Qifa Ye, Yanfeng Wang · 2021 · Artificial Organs
  39. Actividades preventivas en la mujer. Actualización PAPPS 2022
    Alberto López García‐Franco, José Antonio Baeyens Fernández, M. José Iglesias Piñeiro, Pablo Alonso‐Coello, Cristina Ruiz Cabello, Ana Pereira Iglesias, Jacinta Landa Goñi · 2022 · Atención Primaria
  40. Handlungsempfehlungen zur Risikominimierung beim Einsatz von Januskinase‐Inhibitoren zur Therapie chronisch‐entzündlicher Hauterkrankungen
    Johannes Wohlrab, Thomas Kegel, Regina Große, Adina Eichner · 2023 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  41. Hormonelle Kontrazeptiva bei Adoleszentinnen
    Bettina Böttcher, Sabine Elisabeth Segerer · 2023 · Die Gynäkologie
  42. A rare case of superior sagittal sinus thrombosis resulting in the death of a 16-year-old with factor V Leiden, prothrombin G20210A mutation, and oral contraceptive use
    Erik R. Washburn, Mayyadah Al-Nuaimi, Priti Soin, Charles S. Specht · 2023 · Human Pathology Reports
  43. Thrombotic and Vascular Complications of Oral Contraceptives
    Stephen Windisch, William H. Frishman · 2024 · Cardiology in Review
  44. Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs
    Azmi Mohammed, Yaasir H. Mamoojee, Richard Quinton · 2024 · Best Practice & Research Clinical Endocrinology & Metabolism
  45. Oral contraceptive pill phase alters mechanisms contributing to cutaneous microvascular function in response to local heating
    Casey G. Turner, Anna E. Stanhewicz, Karen Emily Nielsen, Jeffrey Scott Otis, Rafaela G. Feresin, Brett James Wong · 2025 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  46. Risk factors venous and arterial thrombosis in young women out of pregnancy
    Natalia K. Vereina, Tatiana V. Movchan, В. С. Чулков · 2020 · Aterotromboz = Atherothrombosis
  47. Hormonelle Kontrazeption und Thrombose
    Christina Hart, Birgit Linnemann · 2021 · DMW - Deutsche Medizinische Wochenschrift
  48. ADENDO: ACTUALIZACIÓN 27/06/2020. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud: Recomendaciones basadas en consenso de expertos e informadas en la evidencia ACIN-IETS. SEGUNDA EDICIÓN.
    Carlos Humberto Saavedra Trujillo · 2020 · Infectio
  49. Hormonal contraception: Is it time to abandon estrogen?
    Mariane Nunes de Nadai, Edson Santos Ferreira Filho, Jarbas Magalhães, Jaqueline Neves Lubianca, Isabel Cristina Espósito Sorpreso, Edmund Chada Baracat, José Maria Soares · 2023 · Human Reproduction Archives
  50. Case Report: Upper limb superficial venous thrombosis associated with oral contraceptives mimicking soft tissue mass
    Jun Hyeong Song, Kyoung‐Chul Chun, Gwan Hee Han, Seung‐Woo Yang, Sang‐Hee Yoon, Jin‐Sung Yuk, Jaeki Ahn, Sang Hyun Nam, Jong‐Woo Kim, Myounghwan Kim · 2023 · Frontiers in Cardiovascular Medicine
  51. Use of combined hormonal contraceptives in women with uterine fibroids: opinions of practitioners
    Natalia V. Aganezova, Аганезов Сергей Станиславович, Шило Мария Михайловна · 2023 · Journal of obstetrics and women s diseases
  52. Awareness of risk when prescribing and taking combined hormonal contraceptives (CHCs): a qualitative study with women and health professionals in three European countries
    Paula Alves, Irene Petersen, Iveta Nagyová, Zuzana Katreniaková, Véra Ehrenstein, Fiona A. Stevenson · 2025 · BMJ Open
  53. Association of Different Formulation with Oral Contraceptive Agents in Lipid and Carbohydrates Metabolism in Women
    Syeda Masooma Hussain, Sikandar Ali Khan, Somaya Noor, Najma Fida, Syed Muhammad Sajid Ali Bukhari, Jahangir Zeb · 2025 · Pakistan Journal of Health Sciences
  54. Risk of venous thromboembolism associated with chlormadinone acetate- and levonorgestrel-containing combined oral contraceptives – Insights from the retrospective RIVET-RCS study
    Pauline De Corte, Moritz Klinghardt, Anja Bauerfeind, Tanja Boehnke, Klaas Heinemann · 2025 · Contraception
  55. Safety of hormonal contraception among women with sickle cell disease: An updated systematic review
    Antoinette T. Nguyen, Preetha Nandi, Andrea Hsu Roe, Lydia H. Pecker, Maura K. Whiteman, Naomi K. Tepper, Kathryn M. Curtis · 2025 · Contraception
  56. Hormonal contraception and risk of major adverse cardiovascular events: A nationwide registry study from Finland
    Eslam A. Edrees, Frida Gyllenberg, Jukka Putaala A, Jari K. Haukka, Oskari Heikinheimo · 2025 · Contraception
  57. Different Methods and Routes of Administration of Hormonal Contraception
    Martin Hans Birkhaeuser · 2026 · Reproductive medicine for clinicians
  58. Oral Contraceptive Use in Obese Adolescents: A Cautionary Tale
    Deepti Warad, Asma Javed Chattha, Vilmarie Rodriguez · 2021 · Journal of Pediatric Hematology/Oncology
  59. The role of factor V Leiden and prothrombin G20210A mutations for clotting in Sudanese women under oral contraceptive use
    Osama Atiatalla Babiker Ahmed, Fathelrahman Mahdi Hassan, Mohammed Asad, Syed Mohammed Basheeruddin Asdaq, Abdulkhaliq Jassem Alsalman, Mohammad Al Mohaini, Abdulhakeem S. Alamri, Walaa Fahad Alsanie, Majid Alhomrani, Maitham Abdullah Al Hawaj et al. · 2021 · Journal of King Saud University - Science
  60. Contraception et maladie thromboembolique veineuse
    Marc Blondon, Alessandro Casini, Pierre Fontana, Justine Hugon‐Rodin · 2020 · JMIG
  61. Influência do anticoncepcional hormonal oral no surgimento da trombose venosa profunda
    Ana Caroline Santos Gondim, Camila Santos Alves de Almeida, Marco Aurélio Ninômia Passos · 2022 · Revista de Divulgação Científica Sena Aires
  62. Übersicht zu hormonellen Kontrazeptiva
    Thomas Römer · 2023 · Die Gynäkologie
  63. Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives
    Elyasa Mustafa Elfaki, Abdulrahman Algarni, Tagwa Yousif Elsayed Yousif, Alneil Hamza, Ezeldine K Abdalhabib, Husham O. Elzein, Eldaw Mohamed Habiballah, Osama A.B. Ahmed, Hussam Ali Osman, Praveen Kumar et al. · 2023 · Blood Coagulation & Fibrinolysis
  64. Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy
    Angelo Cagnacci, Giovanni Grandi, Giampiero Capobianco, Anna Maria Fulghesu, Giuseppe Morgante, Vincenzo Biondelli, Elena Piccolo, Elena Casolati, Mario Mangrella · 2025 · JMIR Research Protocols
  65. Contraception in Systemic Lupus Erythematosus (SLE)
    Faizan Shaukat, Stephanie Keeling · 2019 · Current Treatment Options in Rheumatology
  66. Approach to pulmonary embolism: A clinical care pathway
    Mohamed Toufic El Hussein, Ali Bayrouti · 2021 · Journal of the American Association of Nurse Practitioners
  67. Perspective Chapter: Modern Birth Control Methods
    Rahma Al Kindi, Asma Ali Al Salmani, Rahma Al Hadhrami, Sanaa Al Sumri, Hana Harib Al Sumri · 2022 · IntechOpen eBooks
  68. Thromboembolierisiko unter kombinierten hormonellen Kontrazeptiva – aktueller Stand und Verschreibungspraxis
    Dorothea M. Wunder · 2023 · Praxis
  69. Contraception and Family Planning: New Aspects Related to the Therapeutic Possibilities
    Vincenzina Bruni, Metella Dei · 2024 · Obstetrics and gynecology.
  70. Exploring the use of emergency health services for stroke: what is known about when to seek emergency help and how transport decisions impact in-hospital emergency care
    Damanpreet K. Kandola · 2021
  71. Hormonelle Kontrazeption in Risiko- und Spezialsituationen
    S. Segerer · 2018 · Der Gynäkologe
  72. Female Hormonal Contraception
    Geneviève Plu‐Bureau · 2018 · Elsevier eBooks
  73. Current Resources for Evidence-Based Practice, July 2018
    Kate Woeber, Nicole S. Carlson · 2018 · Journal of Obstetric, Gynecologic & Neonatal Nursing
  74. The Detection of the Embologenic Gigantic Floating Thrombus in the Inferior Vena Cava by Non-Contrast Enhanced Magnetic Resonance Phlebography Under the Outpatient Conditions: a Clinical Case
    K. V. Maizashvili, А А Зорькин, Mikhail S. Pendyurin, R. A. Kolomyts, I. I. Lyubaskiy · 2018 · Journal of Venous Disorders
  75. Vorsicht im ersten Monat nach der Einnahme
    Sarah Kittel‐Schneider · 2018 · InFo Neurologie + Psychiatrie
  76. RISK FACTORS OF THROMBOTIC COMPLICATIONS IN WOMEN USING COMBINED HORMONAL CONTRACEPTIVES
    Natalia K. Vereina, Tatiana V. Movchan, В. С. Чулков · 2019 · Современные проблемы науки и образования
  77. Topical issues in combined oral contraceptives usage
    Дубровина Светлана Олеговна · 2018 · GYNECOLOGY
  78. Hormone Replacement Therapy in Premature Ovarian Insufficiency
    Vincenzina Bruni, Francesca Pampaloni · 2019 · ISGE series
  79. Erworbene und hereditäre Thrombophilien – geeignete kontrazeptive Maßnahmen
    Sabine Elisabeth Segerer, Rupert Martin Bauersachs · 2019 · Gynäkologische Endokrinologie
  80. Œstrogènes et progestatifs. Pharmacologie
    Geneviève Plu‐Bureau, Lorraine Maitrot‐Mantelet, Justine Hugon‐Rodin · 2019 · Elsevier eBooks
  81. "Ağır anovulatuar uterin kanama’" tanısıyla izlenen kız ergenlerin değerlendirilmesi: pediatrist gözüyle ‘aşırı menstrual kanamalar’
    Alkım Öden Akman, Demet Taş · 2020 · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
  82. Contraception in Perimenopausal Patients
    Jennifer A. Reeves, Carrie A. Cwiak · 2020 · Springer eBooks
  83. Endocrinological Care for Patients Undergoing Gender Affirmation (Including Risk of Thromboembolic Events)
    Lei Min, Rachel L. Hopkins · 2021 · Springer eBooks
  84. Drug Utilization Study on Oral Contraceptives provided from Social Security, Buenos Aires-Argentina: Risk and cost analysis according to the type of combination used
    Lupe Marín, Luis Blanco, Gina Marin, Sergio Agüero, Mariana Pagnotta, Gustavo Horacio Marin · 2020 · Journal of Drug Delivery and Therapeutics
  85. Oral Contraceptive Use in Obese Adolescents: A Cautionary Tale
    Vilmarie Rodriguez, Deepti Warad, Asma Javed Chattha · 2020
  86. Progestageners terminologi - en presisering
    Guttorm Raknes · 2021 · Tidsskrift for Den norske legeforening
  87. Thromboembolierisiko unter kombinierten hormonellen Kontrazeptiva – aktueller Stand und Verschreibungspraxis
    Dorothea M. Wunder, Gabriele S. Merki‐Feld · 2021 · Gynäkologische Endokrinologie
  88. CONCEPT MAPPING IN THE STUDY OF PHYSICAL CONCEPTS WITH TEACHER STUDENTS OF PRIMARY EDUCATION (APPLICATION TO BUOYANCY)
    C. Aguirre-Pérez · 2010 · EDULEARN proceedings
  89. The combined oral contraceptive pill
    Laura Patterson · 2022 · InnovAiT Education and inspiration for general practice
  90. Ocena wpływu stosowania antykoncepcji hormonalnej na występowanie objawów przewlekłej choroby żylnej u młodych kobiet
    Julia Graca, Marta Gromada, Paweł Gruchalski, Tomasz Urbanek · 2022 · Chirurgia Polska
  91. Estetrol: ¿un nuevo paradigma en terapia ginecológica?
    Teresa Navarrete Horta, Francisco Javier Guerrero Carreño, Paulina Valdez Aguerrebere, Leopoldo Alejandro Vázquez Estrada · 2022 · Acta Médica Grupo Ángeles
  92. Hormonelle Kontrazeption und Thrombose
    Christina Hart, Birgit Linnemann · 2022 · Phlebologie
  93. Increase of Oxidative Stress is Positively Associated with High-Sensitivity C-Reactive Protein in Women Using Combined Oral Contraceptives: An Observational Study
    Sabina Cauci, Maria Pia Francescato, Chiara Colannino, Mattia Barbina, Giuseppe Barbina, Serena Xodo · 2020
  94. Transition period of estrogen-progestogen hormone therapy
    Irina V. Kuznetsova · 2019 · Medical alphabet
  95. Contraception
    Sherif A. Shazly, Shannon K. Laughlin-Tommaso · 2020 · Springer eBooks
  96. Efficacy of Guizhi Fuling Wan for Primary dysmenorrhea: protocol for a randomised controlled trial
    Yun Ke Du, Yatong Li, Xianyun Fu, Yanan Luo, Chenjie Li · 2021 · Research Square
  97. High Altitude Induced Thrombosis: Challenges and Recent Advancements in Pathogenesis and Management
    Tarun Tyagi, Kanika Jain · 2022 · Springer eBooks
  98. Klinische Herausforderungen bei der Diagnostik und Therapie von PCOS in der Adoleszenz
    Iris Holzer · 2022 · Journal für Gynäkologische Endokrinologie/Österreich
  99. Blutgerinnung und hormonelle Kontrazeptiva
    Rainer Bernd Zotz, Christina Hart, Jan Beyer‐Westendorf, Hannelore Rott, Birgit Linnemann · 2022 · Gynäkologische Endokrinologie
  100. MODERN VIEWS ON THE MANAGEMENT OF SAFE ABORTION AND TACTICS FOR MAINTAINING REPRODUCTIVE HEALTH AFTER AN EARLY ABORTION
    A.A. Sukhanova, K.D. Bodashevska · 2022 · Scientific digest of association of obstetricians and gynecologists of Ukraine